REBECCA BROWN: Open Payments
NPI 1679055008 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,346 in 102 payments from 17 companies in 2025. Trend: 2023 $2,223 · 2024 $2,557 · 2025 $3,346
Food & beverage: $3,346
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $811 |
| Janssen Biotech, Inc. | 10 | $501 |
| Madrigal Pharmaceuticals | 10 | $362 |
| Regeneron Healthcare Solutions, Inc. | 8 | $274 |
| PFIZER INC. | 11 | $224 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $204 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $176 |
| Celltrion USA Inc. | 8 | $151 |
| Ardelyx, Inc. | 4 | $132 |
| Aimmune Therapeutics, Inc. | 5 | $123 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, RINVOQ, XIFAXAN, ENTYVIO, LINZESS, VEGZELMA.
Industry payments across TN — which companies pay providers there.
